Hyperoside demonstrates potential anti-gastric cancer properties by regulating the cell cycle, activating apoptosis-related signaling pathways, and inhibiting NF-κB and Wnt/β-Catenin signal transduction. The gene discussed is NFKB1; the disease is gastric cancer.